|
Model Number FT4 G3 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/09/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
Na.
|
|
Event Description
|
The initial reporter stated they received discrepant results for one patient sample tested with elecsys ft3 iii (ft3) and the elecsys ft4 iii assay on two cobas 8000 e 801 modules.The sample also had a discrepant result for elecsys ft3 iii ver.2 (ft3 v2) when tested on the second e 801 analyzer.The results measured at the customer site were reported outside of the laboratory to a physician.This medwatch will apply to the ft4 assay.Please refer to the medwatch with patient identifier (b)(6) for information related to the ft3 assay and refer to the medwatch with patient identifier (b)(6) for information related to the ft3 v2 assay.Refer to the attachment for all patient data.Values highlighted in yellow are questionable.The sample was initially tested for ft3 and ft4 on the customer's e 801 analyzer on (b)(6) 2021.The sample was repeated using the wako accuraseed ft3 and ft4 methods.The sample was treated with polyethylene glycol (peg) and repeated on the customer's e 801 analyzer.The sample was also provided for investigation, where it was tested for ft3, ft3 v2, and ft4 on a second e 801 analyzer.The serial number of the customer's e 801 analyzer is (b)(4).The ft4 reagent lot number and expiration date used on this analyzer were requested, but not provided.The serial number of the e 801 analyzer used for investigation is (b)(4).Ft4 reagent lot number 541093, with an expiration date of 31-may-2022 was used on this analyzer.
|
|
Manufacturer Narrative
|
The patient sample was repeated on an abbott architect analyzer, resulting in a ft3 value of 2.91 pg/ml (reference range = 1.68 - 3.67 pg/ml) and a ft4 value of 1.34 ng/dl (reference range = 0.7 - 1.48 ng/dl).For the ft4 results, assays from different vendors can generate different values.This is related to the overall setups of the assays, the antibodies used, differences in reference materials/methods, and differences in the standardization methodology used.
|
|
Search Alerts/Recalls
|
|
|